DIFELIKEFALIN (Kapruvia®)
Clinical Indication
For moderate to severe pruritus in adults with chronic kidney disease (CKD) having in-centre haemodialysis
Comments
In line with NICE TA890
Date of classification
January 2023
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.